A View LCS vs iCAC Device
AI Verdict
Choose A View LCS if…
Choose A View LCS if your institution requires a comprehensive, dedicated AI solution for lung cancer screening programs that also integrates emphysema quantification and detailed coronary artery calcification assessment from a single low-dose CT scan. This tool is ideal for a multi-specialty approach to thoracic health, providing automated nodule detection, Lung-RADS scoring, and advanced cardiac artery segmentation.
View A View LCS →Choose iCAC Device if…
Choose iCAC Device if your primary goal is the opportunistic identification and quantification of coronary artery calcium from routine, non-contrast, non-gated chest CT scans already performed for other clinical indications. This solution is best suited for leveraging existing imaging data to provide adjunctive cardiovascular risk information without requiring additional dedicated scans.
View iCAC Device →When choosing between AVIEW LCS and iCAC Device, physicians should consider their primary diagnostic focus and workflow integration needs. AVIEW LCS offers a comprehensive thoracic CT analysis, making it ideal for practices focused on lung cancer screening, emphysema quantification, and detailed coronary artery calcification (CAC) detection from a single low-dose CT scan. Its robust feature set includes automated lung nodule detection and classification, Lung-RADS scoring, and detailed emphysema analysis, alongside CAC scoring with segmentation of major coronary arteries. This tool is best suited for pulmonologists and radiologists requiring a multi-faceted thoracic assessment.
In contrast, the iCAC Device specializes in the opportunistic identification and quantification of coronary artery calcium from routine, non-contrast, non-gated chest CT scans. Its key practical difference lies in its ability to leverage existing CT scans for cardiovascular risk assessment, providing adjunctive information to radiologists without requiring dedicated cardiac CT protocols. This makes it a strong choice for cardiologists and radiologists primarily interested in efficiently screening for cardiovascular disease using readily available imaging data. Physicians whose workflow benefits from a broader thoracic analysis should lean towards AVIEW LCS, while those prioritizing efficient, targeted CAC detection from diverse CT scan types may find iCAC Device more aligned with their needs.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | A View LCS | iCAC Device |
|---|---|---|
| Pricing | Contact for quote | Contact for pricing |
| Deployment | Cloud-based, Hybrid solution, Locally on dedicated hardware, Locally virtualized (virtual machine, Docker) | Software as a Medical Device (SaMD), integrates with PACS or DICOM router. Cloud-based (via Carebricks platform). |
| FDA Status | 1 AI-estimated | 1 AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
A View LCSTool A offers a broader range of analyses (lung nodules, emphysema, CAC) within a single platform, potentially streamlining multiple diagnostic workflows. Its comprehensive reporting options (PDF, DICOM PDF, SR) and CT kernel conversion AI technology also suggest a focus on simplifying user interaction and data handling.
Clinical Value
A View LCSTool A provides comprehensive thoracic CT analysis, simultaneously addressing lung cancer screening, emphysema quantification, and coronary artery calcification from a single low-dose CT scan. This multi-faceted assessment offers a broader clinical utility by consolidating diagnostics for several major health concerns.
Pricing & Value
TieBoth Tool A and Tool B require direct contact with the vendor for pricing information. Without transparent pricing details, it is impossible to conduct a meaningful comparison of their respective value propositions.
Enterprise Readiness
A View LCSTool A explicitly states it is HIPAA compliant and has a Business Associate Agreement (BAA) in place, which are critical for enterprise adoption in healthcare. Furthermore, it offers diverse deployment options including cloud, hybrid, local dedicated hardware, and virtualized solutions, providing greater flexibility for integration into various IT infrastructures.
Innovation
iCAC DeviceTool B's key innovation lies in its ability to detect and quantify coronary artery calcium from routine, non-contrast, non-gated chest CT scans, enabling opportunistic identification of cardiovascular disease. This approach leverages existing imaging data to provide new clinical insights without requiring additional dedicated scans, representing a significant advancement in proactive health screening.
Support & Docs
TieThe provided structured facts and subsequent web searches do not contain specific information regarding the availability, scope, or quality of support services or documentation for either Tool A or Tool B. Therefore, a comparative assessment is not possible.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | A View LCS | iCAC Device |
|---|---|---|
| Name | A View LCS | iCAC Device |
| Company | Coreline Soft Co. | Bunkerhill Health |
| Primary Focus | AI-powered medical imaging for comprehensive thoracic CT analysis, specializing in lung cancer screening, emphysema quantification, and coronary artery calcification detection from a single low-dose CT scan. | FDA-cleared AI algorithm that detects and quantifies coronary artery calcium from routine, non-contrast, non-gated chest CT scans, aiding in early cardiovascular disease detection. |
| Categories | Cardiology AI, Oncology AI, Radiology & Imaging AI | Cardiology AI |
| Specialties | Cardiology, Pulmonology, Radiology | Cardiology, Radiology |
| Coronary Artery Calcium (CAC) Capabilities | CAC scoring (Agatston, volume, mass), Segmentation of major coronary arteries | Estimates presence and quantity of coronary artery calcium (CAC), Analyzes routine, non-contrast, non-gated chest CT scans, Utilizes deep-learning algorithms for analysis, Outputs visual representation of estimated CAC segmentation, Delivers exact and four-category quantitative estimates of CAC burden in Agatston units, Supports opportunistic identification of CAC from existing CT scans |
| Other Thoracic Analysis Features | Automated lung nodule detection and classification, Nodule volume quantification and measurement (3D), Lung-RADS scoring and reporting, Emphysema analysis and quantification (LAA), Automated comprehensive report generation (PDF, DICOM PDF, SR), CT kernel conversion AI technology | Provides adjunctive information to radiologists, Integrates with EHRs via the Carebricks platform |
Videos
Demos, reviews, and walkthroughs featuring A View LCS and iCAC Device.